NOVN 📈 Novartis - Overview

Novartis AG is a multinational healthcare company that operates in the research, development, manufacturing, and marketing of a wide range of healthcare products globally. With its headquarters in Basel, Switzerland, the company has established itself as a major player in the pharmaceutical industry, offering a diverse portfolio of prescription medicines for patients and physicians. Its product lineup includes innovative treatments such as Pluvicto, a therapy designed for adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer, and Lutathera, a prescription medicine used to treat gastroenteropancreatic neuroendocrine tumors in adults and children aged 12 years and older.

The company's focus areas include cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology, allowing it to address various unmet medical needs. To further expand its offerings, Novartis AG has entered into strategic partnerships, such as a license and collaboration agreement with Alnylam Pharmaceuticals to develop and commercialize inclisiran, a therapy aimed at reducing LDL cholesterol levels. Additionally, the company has collaborated with Dawn Health to develop and commercialize Ekiva, a digital solution designed to support individuals living with Paroxysmal Nocturnal Hemoglobinuria.

Novartis AG has also established research collaborations with companies like Schrödinger, Inc. to identify and develop novel therapeutic candidates, and a strategic collaboration with Vyriad, Inc. for the discovery and development of in vivo chimeric antigen receptor T-cell therapies. With a strong foundation in research and development, the company has been at the forefront of innovation in the pharmaceutical industry since its incorporation in 1996. As a publicly traded company, Novartis AG's common stock is listed under the ISIN CH0012005267, and it is classified under the GICS Sub Industry: Pharmaceuticals.

Through its commitment to delivering innovative healthcare solutions, Novartis AG has established a significant presence in the global pharmaceutical market. The company's official website, https://www.novartis.com, provides detailed information on its products, research initiatives, and strategic partnerships, offering insights into its mission to improve patient outcomes and address pressing healthcare challenges. With its diversified portfolio and collaborative approach, Novartis AG continues to play a vital role in shaping the future of healthcare.